Advanced Cell Technology gets 2 patents related to retinal cells

09/15/2010 | Mass High Tech (Boston)

Advanced Cell Technology has received a patent to use retinal pigment epithelial cells derived from human embryonic stem cells in the treatment of retinal degeneration. The company also received another patent that allows it to produce RPE cells for use in transplantation. The patents will enable the company to test its cell treatment for Stargardt's disease.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN